Histopathologic Features in Vancomycin‐Associated Drug‐Induced Hypersensitivity Syndrome
Journal of Cutaneous Pathology · 2025
DOI: 10.1111/cup.14804 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cutaneous Pathology, 2025. Verfasst von Hannah B Haberecht und 11 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic Alix School of Medicine, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Vancomycin, Drug Hypersensitivity Syndrome, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Background
Drug‐induced hypersensitivity syndrome (DiHS), or drug reaction with eosinophilia and systemic symptoms (DRESS), is a delayed and severe immune response to certain medications. We investigated vancomycin‐induced DiHS/DRESS, notable for frequent and severe organ involvement, to describe its specific histopathology and the correlations between histopathologic and clinical findings.
Methods
A retrospective review was conducted to identify patients between 2006 and 2022 who received vancomycin, had archived skin biopsy specimens, and were scored as having probable or definite DiHS/DRESS. Clinical features were retrospectively collected, and biopsy specimens were reviewed by a board‐certified dermatopathologist. A subset of histopathologic and clinical features was analyzed for statistical correlation.
Results
Twenty‐three patients met the inclusion criteria. Most biopsy specimens (87%) showed an eczematous reaction pattern; 17 (74%) showed a secondary reaction pattern. Spongiosis (87%) and neutrophilic infiltration (91%) were common epidermal characteristics. The dermal inflammatory infiltrate was frequently superficial (87%) and consistently included plasma cells (96%). Eosinophils were present in the dermis in 70% of cases. Parakeratosis negatively correlated with liver involvement and positively correlated with desquamative rash. Epidermal lymphocytes were negatively correlated with the RegiSCAR score.
Conclusions
Vancomycin‐associated DiHS/DRESS histopathology was characterized by a frequent eczematous reaction pattern, multiple coexisting reaction patterns, and epidermal neutrophilic infiltration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mayo Clinic Alix School of Medicine, Rochester, Minnesota, USA.
- Mayo Clinic Division of Clinical Trials and Biostatistics, Rochester, Minnesota, USA.
- Mayo Clinic Department of Dermatology, Rochester, Minnesota, USA.
- Mayo Clinic Department of Laboratory Medicine and Pathology, Rochester, Minnesota, USA.
ORCID-Profile: Hannah B Haberecht
Zitieren
APA
Haberecht, H. B., Ziebart, R. L., Iverson, O. C., Todd, A., Davis, M. D., Wetter, D. A., Sartori-Valinotti, J. C., Cantwell, H. M., McEvoy, M. T., Mohandesi, N. A., Alavi, A., & Johnson, E. F. (2025). Histopathologic Features in Vancomycin‐Associated Drug‐Induced Hypersensitivity Syndrome. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14804
Vancouver
Haberecht HB, Ziebart RL, Iverson OC, Todd A, Davis MD, Wetter DA, et al. Histopathologic Features in Vancomycin‐Associated Drug‐Induced Hypersensitivity Syndrome. Journal of Cutaneous Pathology. 2025. doi:10.1111/cup.14804
BibTeX
@article{Haberecht2025,
author = {Haberecht, Hannah B and Ziebart, Rachel L and Iverson, Olivia C and Todd, Austin and Davis, Mark D and Wetter, David A and Sartori-Valinotti, Julio C and Cantwell, Hafsa M and McEvoy, Marian T and Mohandesi, Nessa Aghazadeh and Alavi, Afsaneh and Johnson, Emma F},
title = {Histopathologic Features in Vancomycin‐Associated Drug‐Induced Hypersensitivity Syndrome},
journal = {Journal of Cutaneous Pathology},
year = {2025},
doi = {10.1111/cup.14804}
}
EUVIMED